CSIMarket


Immuron Limited  (IMRN)
Other Ticker:  
 

Immuron Limited

IMRN's Fundamental analysis








Immuron Limited's sales fell in IV. Quarter 2022 from the same quarter a year ago.

Major Pharmaceutical Preparations industry recorded growth of revenues by 9.63 %



More on IMRN's Growth


Immuron Limited
realized net loss in trailing twelve months.

Company
PE TTM   
Industry
0.01
PE TTM    
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 4.69.


More on IMRN's Valuation
 
 Total Debt (Millions $) -
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Revenue/Employee (TTM) $ -
 Net Income/Employee (TTM) $ -
 Receivable Turnover (TTM) -
 Tangible Book Value (Per Share $)

Immuron Limited
realized net loss in trailing twelve months.

Company
PE TTM   
Industry
0.01
PE TTM    
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 4.69.